Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.72
CAH's Cash to Debt is ranked higher than
61% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.63 vs. CAH: 0.72 )
CAH' s 10-Year Cash to Debt Range
Min: 0.01   Max: 1.29
Current: 0.72

0.01
1.29
Equity to Asset 0.25
CAH's Equity to Asset is ranked lower than
54% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.38 vs. CAH: 0.25 )
CAH' s 10-Year Equity to Asset Range
Min: 0.23   Max: 0.43
Current: 0.25

0.23
0.43
F-Score: 7
Z-Score: 4.87
M-Score: -2.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 0.99
CAH's Operating margin (%) is ranked lower than
62% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.78 vs. CAH: 0.99 )
CAH' s 10-Year Operating margin (%) Range
Min: 0.99   Max: 4.22
Current: 0.99

0.99
4.22
Net-margin (%) 0.33
CAH's Net-margin (%) is ranked lower than
62% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.78 vs. CAH: 0.33 )
CAH' s 10-Year Net-margin (%) Range
Min: 0.33   Max: 2.48
Current: 0.33

0.33
2.48
ROE (%) 5.59
CAH's ROE (%) is ranked lower than
58% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. CAH: 5.59 )
CAH' s 10-Year ROE (%) Range
Min: 5.59   Max: 26.18
Current: 5.59

5.59
26.18
ROA (%) 1.29
CAH's ROA (%) is ranked lower than
58% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.39 vs. CAH: 1.29 )
CAH' s 10-Year ROA (%) Range
Min: 1.29   Max: 8.34
Current: 1.29

1.29
8.34
ROC (Joel Greenblatt) (%) 33.92
CAH's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 34.71 vs. CAH: 33.92 )
CAH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 24.77   Max: 58.01
Current: 33.92

24.77
58.01
Revenue Growth (%) 2.50
CAH's Revenue Growth (%) is ranked higher than
51% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.50 vs. CAH: 2.50 )
CAH' s 10-Year Revenue Growth (%) Range
Min: 2.5   Max: 39.4
Current: 2.5

2.5
39.4
EBITDA Growth (%) -2.50
CAH's EBITDA Growth (%) is ranked lower than
52% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.60 vs. CAH: -2.50 )
CAH' s 10-Year EBITDA Growth (%) Range
Min: -11.9   Max: 48.9
Current: -2.5

-11.9
48.9
EPS Growth (%) -15.70
CAH's EPS Growth (%) is ranked lower than
56% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. CAH: -15.70 )
CAH' s 10-Year EPS Growth (%) Range
Min: -15.7   Max: 30.9
Current: -15.7

-15.7
30.9
» CAH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CAH Guru Trades in Q3 2013

Jim Simons 21,700 sh (New)
Joel Greenblatt 143,906 sh (+772.85%)
Pioneer Investments 1,647,508 sh (+107.35%)
Ray Dalio 75,346 sh (+62.57%)
John Keeley 123,300 sh (+14.72%)
James Barrow 11,518,013 sh (+9.34%)
John Buckingham 17,502 sh (+2.76%)
Manning & Napier Advisors, Inc 30,769 sh (+1.38%)
Vanguard Health Care Fund 8,304,241 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones Sold Out
RS Investment Management 1,178,531 sh (-10.39%)
Jeremy Grantham 426,663 sh (-28.35%)
Steven Cohen 3,896 sh (-96.85%)
David Dreman 2,019 sh (-97.55%)
» More
Q4 2013

CAH Guru Trades in Q4 2013

Caxton Associates 60,901 sh (New)
Paul Tudor Jones 304,200 sh (New)
Steven Cohen 15,860 sh (+307.08%)
Jim Simons 44,000 sh (+102.76%)
Joel Greenblatt 257,325 sh (+78.81%)
John Keeley 164,270 sh (+33.23%)
Pioneer Investments 1,967,912 sh (+19.45%)
John Buckingham 18,267 sh (+4.37%)
David Dreman Sold Out
James Barrow 8,532,117 sh (-25.92%)
RS Investment Management 842,804 sh (-28.49%)
Manning & Napier Advisors, Inc 19,477 sh (-36.7%)
Vanguard Health Care Fund 5,043,241 sh (-39.27%)
Ray Dalio 25,646 sh (-65.96%)
Jeremy Grantham 97,397 sh (-77.17%)
» More
Q1 2014

CAH Guru Trades in Q1 2014

Louis Moore Bacon 6,078 sh (New)
Ray Dalio 48,844 sh (+90.45%)
Joel Greenblatt 379,308 sh (+47.4%)
Steven Cohen 17,553 sh (+10.67%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Jim Simons Sold Out
John Buckingham 18,131 sh (-0.74%)
Manning & Napier Advisors, Inc 18,931 sh (-2.8%)
Pioneer Investments 1,856,220 sh (-5.68%)
John Keeley 149,817 sh (-8.8%)
Caxton Associates 50,000 sh (-17.9%)
James Barrow 6,958,722 sh (-18.44%)
Paul Tudor Jones 233,468 sh (-23.25%)
Jeremy Grantham 56,000 sh (-42.5%)
RS Investment Management 418,304 sh (-50.37%)
» More
Q2 2014

CAH Guru Trades in Q2 2014

Jim Simons 123,000 sh (New)
Joel Greenblatt 680,062 sh (+79.29%)
John Buckingham 18,175 sh (+0.24%)
Vanguard Health Care Fund 5,043,241 sh (unchged)
Louis Moore Bacon 6,078 sh (unchged)
Caxton Associates 128,800 sh (unchged)
Jeremy Grantham Sold Out
Caxton Associates Sold Out
Manning & Napier Advisors, Inc Sold Out
John Keeley 145,907 sh (-2.61%)
James Barrow 6,620,964 sh (-4.85%)
RS Investment Management 372,364 sh (-10.98%)
Pioneer Investments 1,375,212 sh (-25.91%)
Ray Dalio 10,834 sh (-77.82%)
Paul Tudor Jones 9,159 sh (-96.08%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Add 79.29%0.26%$63.8 - $71.31 $ 73.78%680062
Ray Dalio 2014-06-30 Reduce -77.82%0.02%$63.8 - $71.31 $ 73.78%10834
James Barrow 2014-03-31 Reduce -18.44%0.15%$65.26 - $73.54 $ 73.76%6958722
Joel Greenblatt 2014-03-31 Add 47.4%0.13%$65.26 - $73.54 $ 73.76%379308
Ray Dalio 2014-03-31 Add 90.45%0.01%$65.26 - $73.54 $ 73.76%48844
Vanguard Health Care Fund 2013-12-31 Reduce -39.27%0.59%$52.95 - $67.48 $ 73.720%5043241
James Barrow 2013-12-31 Reduce -25.92%0.25%$52.95 - $67.48 $ 73.720%8532117
Joel Greenblatt 2013-12-31 Add 78.81%0.18%$52.95 - $67.48 $ 73.720%257325
John Keeley 2013-12-31 Add 33.23%0.05%$52.95 - $67.48 $ 73.720%164270
Ray Dalio 2013-12-31 Reduce -65.96%0.02%$52.95 - $67.48 $ 73.720%25646
David Dreman 2013-12-31 Sold Out 0.01%$52.95 - $67.48 $ 73.720%0
Joel Greenblatt 2013-09-30 Add 772.85%0.21%$47.02 - $53.57 $ 73.745%143906
David Dreman 2013-09-30 Reduce -97.55%0.13%$47.02 - $53.57 $ 73.745%2019
John Hussman 2013-09-30 Sold Out 0.01%$47.02 - $53.57 $ 73.745%0
Ray Dalio 2013-09-30 Add 62.57%0.01%$47.02 - $53.57 $ 73.745%75346
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Cardinal Health Inc

Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Allergan
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Cardinal Health Inc, Envision Healthcare Holdings Inc, Tableau Software Inc, and Allergan Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 21.80
CAH's P/E(ttm) is ranked higher than
69% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.90 vs. CAH: 21.80 )
CAH' s 10-Year P/E(ttm) Range
Min: 6.28   Max: 73.63
Current: 21.8

6.28
73.63
P/B 3.92
CAH's P/B is ranked lower than
55% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.40 vs. CAH: 3.92 )
CAH' s 10-Year P/B Range
Min: 0.86   Max: 3.92
Current: 3.92

0.86
3.92
P/S 0.28
CAH's P/S is ranked higher than
82% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. CAH: 0.28 )
CAH' s 10-Year P/S Range
Min: 0.08   Max: 0.39
Current: 0.28

0.08
0.39
PFCF 11.17
CAH's PFCF is ranked higher than
96% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 80.67 vs. CAH: 11.17 )
CAH' s 10-Year PFCF Range
Min: 4.16   Max: 36.5
Current: 11.17

4.16
36.5
EV-to-EBIT 13.30
CAH's EV-to-EBIT is ranked higher than
78% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.68 vs. CAH: 13.30 )
CAH' s 10-Year EV-to-EBIT Range
Min: 4.8   Max: 25.5
Current: 13.3

4.8
25.5
Shiller P/E 27.45
CAH's Shiller P/E is ranked higher than
73% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 37.62 vs. CAH: 27.45 )
CAH' s 10-Year Shiller P/E Range
Min: 5.96   Max: 27.5
Current: 27.45

5.96
27.5
Current Ratio 1.19
CAH's Current Ratio is ranked lower than
56% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.43 vs. CAH: 1.19 )
CAH' s 10-Year Current Ratio Range
Min: 1.19   Max: 1.83
Current: 1.19

1.19
1.83
Quick Ratio 0.64
CAH's Quick Ratio is ranked lower than
65% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. CAH: 0.64 )
CAH' s 10-Year Quick Ratio Range
Min: 0.53   Max: 0.84
Current: 0.64

0.53
0.84

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.70
CAH's Dividend Yield is ranked higher than
51% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.65 vs. CAH: 1.70 )
CAH' s 10-Year Dividend Yield Range
Min: 0.22   Max: 2.66
Current: 1.7

0.22
2.66
Dividend Payout 0.37
CAH's Dividend Payout is ranked higher than
78% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.81 vs. CAH: 0.37 )
CAH' s 10-Year Dividend Payout Range
Min: 0.03   Max: 1.8
Current: 0.37

0.03
1.8
Dividend growth (3y) 14.80
CAH's Dividend growth (3y) is ranked higher than
78% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.70 vs. CAH: 14.80 )
CAH' s 10-Year Dividend growth (3y) Range
Min: 10.8   Max: 49.4
Current: 14.8

10.8
49.4
Yield on cost (5-Year) 3.66
CAH's Yield on cost (5-Year) is ranked higher than
69% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.06 vs. CAH: 3.66 )
CAH' s 10-Year Yield on cost (5-Year) Range
Min: 0.47   Max: 5.73
Current: 3.66

0.47
5.73
Share Buyback Rate 1.60
CAH's Share Buyback Rate is ranked higher than
86% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. CAH: 1.60 )
CAH' s 10-Year Share Buyback Rate Range
Min: 5.8   Max: -22.9
Current: 1.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 47.24
CAH's Price/Tangible Book is ranked higher than
51% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.59 vs. CAH: 47.24 )
CAH' s 10-Year Price/Tangible Book Range
Min: 2.48   Max: 44.33
Current: 47.24

2.48
44.33
Price/DCF (Projected) 1.33
CAH's Price/DCF (Projected) is ranked higher than
75% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.39 vs. CAH: 1.33 )
CAH' s 10-Year Price/DCF (Projected) Range
Min: 0.3   Max: 6.18
Current: 1.33

0.3
6.18
Price/Median PS Value 1.64
CAH's Price/Median PS Value is ranked higher than
51% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.31 vs. CAH: 1.64 )
CAH' s 10-Year Price/Median PS Value Range
Min: 0.47   Max: 5.32
Current: 1.64

0.47
5.32
Price/Graham Number 6.72
CAH's Price/Graham Number is ranked higher than
60% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.11 vs. CAH: 6.72 )
CAH' s 10-Year Price/Graham Number Range
Min: 0.95   Max: 9.2
Current: 6.72

0.95
9.2
Earnings Yield (Greenblatt) 7.50
CAH's Earnings Yield (Greenblatt) is ranked higher than
72% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.80 vs. CAH: 7.50 )
CAH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 20.8
Current: 7.5

3.9
20.8
Forward Rate of Return (Yacktman) 5.38
CAH's Forward Rate of Return (Yacktman) is ranked higher than
50% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.61 vs. CAH: 5.38 )
CAH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.6   Max: 28.6
Current: 5.38

2.6
28.6

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, SHTDF, HSIC, PDCO » details
Traded in other countries:CLH.Germany
Cardinal Health, Inc is an Ohio corporation formed in 1979. It is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health, Inc. also provides medical products to patients in the home. The Company has two operating segments: Pharmaceutical and Medical. The Pharmaceutical segment recognizes distribution revenue when title transfers to its customers and the Company have further obligation to provide services related to such merchandise. Radiopharmaceutical revenue is recognized upon delivery of the product to the customer and the Company has no further obligation to provide services related to such merchandise. The Medical segment recognizes revenue when title transfers to its customers and the Company have no further obligation to provide services related to such merchandise. In the Pharmaceutical segment, it competes with wholesale distributors with national reach (including McKesson Corporation, AmerisourceBergen Corporation and H.D. Smith. In the Medical segment, it compete with many different distributors, including Owens & Minor, Inc., Thermo Fisher Scientific Inc., McKesson Corporation, Henry Schein, Inc., Medline Industries, Inc., Mediq NV (through Byram Healthcare) and CCS Medical Holdings, Inc. . The Company's operations are affected by federal, state and local environmental laws.
» More Articles for CAH

Headlines

Articles On GuruFocus.com
Top Insider Sells Highlight: Cardinal Health Inc. Jul 17 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
8 Dividend Stocks with a 15% Yield in 15 Years May 14 2014 
7 Stocks Building Shareholder Returns with Higher Dividends May 12 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and Alle Feb 16 2014 
Weekly CFO Sells Highlight: Facebook Inc., Cardinal Health Inc., Alexion Pharmaceuticals Inc., Therm Feb 10 2014 
Cardinal Health Inc. Dividend Stock Analysis Dec 13 2013 
6 Health Care Stocks with Growing Dividends Yielding in Excess of 2% Oct 09 2013 
4 Good Looking Dividend Stocks with High Beta Ratios from the Services Sector Aug 08 2013 

More From Other Websites
Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission Aug 29 2014
4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner Aug 28 2014
CARDINAL HEALTH INC Financials Aug 22 2014
Top Analyst Upgrades and Downgrades: Achillion, GE, Monster, Newmont, SeaWorld and More Aug 18 2014
Cardinal Health Gains on Enhanced Share Repurchase Program Aug 14 2014
CARDINAL HEALTH INC Files SEC form 10-K, Annual Report Aug 13 2014
Fred's And Cardinal Health Announce Primary Supply Agreement Aug 11 2014
CARDINAL HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Aug 06 2014
Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Increase to Share... Aug 06 2014
[$$] 3 Stocks With Rising Sales Estimates Worth Buying Aug 05 2014
Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL Aug 05 2014
[video] Cramer looks for bright spots in the market Aug 04 2014
[video] The Top Ten Stocks for Aug. 4 Aug 04 2014
U.S. stocks rally; Dow snaps 4-session losing streak Aug 04 2014
Cardinal Health Conference Call Highlights Aug 04 2014
[video] Cardinal Health Beats Estimates but Sees Big Drop in Revenue Aug 04 2014
Cardinal Health's Fiscal Q4 Earnings Rise and Beat Estimates Aug 04 2014
Why Cardinal Health (CAH) Stock Is Down Today Aug 04 2014
Cardinal Health Guides Low As Revenue Keeps Sliding Aug 04 2014
Stocks to Watch: Cardinal Health, Pike, Michael Kors Aug 04 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK